Earnings results for Achieve Life Sciences (NASDAQ:ACHV)
Achieve Life Sciences, Inc. is expected* to report earnings on 03/11/2021 after market close. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-1.27. The reported EPS for the same quarter last year was $-6.
Analyst Opinion on Achieve Life Sciences (NASDAQ:ACHV)
3 Wall Street analysts have issued ratings and price targets for Achieve Life Sciences in the last 12 months. Their average twelve-month price target is $50.33, predicting that the stock has a possible upside of 327.64%. The high price target for ACHV is $100.00 and the low price target for ACHV is $21.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Achieve Life Sciences has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $50.33, Achieve Life Sciences has a forecasted upside of 327.6% from its current price of $11.77. Achieve Life Sciences has received no research coverage in the past 90 days.
Dividend Strength: Achieve Life Sciences (NASDAQ:ACHV)
Achieve Life Sciences does not currently pay a dividend. Achieve Life Sciences does not have a long track record of dividend growth.
Insiders buying/selling: Achieve Life Sciences (NASDAQ:ACHV)
In the past three months, Achieve Life Sciences insiders have not sold or bought any company stock. Only 2.30% of the stock of Achieve Life Sciences is held by insiders. Only 12.54% of the stock of Achieve Life Sciences is held by institutions.
Earnings and Valuation of Achieve Life Sciences (NASDAQ:ACHV
Earnings for Achieve Life Sciences are expected to grow in the coming year, from ($5.94) to ($5.34) per share. The P/E ratio of Achieve Life Sciences is -1.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Achieve Life Sciences is -1.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Achieve Life Sciences has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.
More latest stories: here